Author Archives: Site Administrator
U.S. Settles with Accredo Health, Intervenes Against Novartis
According to the Justice Department, specialty pharmacy, Accredo Health Group, has agreed to pay $60 million to settle allegations that it violated the False Claims Act in connection with a kickback scheme involving the prescription drug Exjade. The government announced that it has intervened in the portion of the case against Novartis Pharmaceuticals Corp…. Read More »
Family Dermatology, P.C. Agrees to Settle False Claims Act Cases
According the U.S. Department of Justice, Family Dermatology, P.C. (“Family Dermatology”), based in Lilburn, Georgia, has agreed to settle allegations that it violated the Stark Law and False Claims Act. The government said the allegations concerned financial relationships Family Dermatology and its affiliated companies had with dermatologists they employed as independent contractors. According to… Read More »
Texas Hospital Settles False Claims Act and Stark Law Case
According to the Department of Justice, Citizens Medical Center (“Citizens”) located in Victoria, Texas has agreed to pay $21.75 million to settle a qui tam case brought by three whistleblowers alleging violations of the False Claims Act and the Stark Law. In addition to Citizens, the whistleblowers named the hospital’s administrator, David Brown, and… Read More »
Government Intervenes in HCR ManorCare Qui Tam Suits
According to the Department of Justice, the federal government has filed a consolidated complaint intervening in three whistleblowers’ qui tam lawsuits alleging that HCR ManorCare and its affiliates violated the False Claims Act. The Justice Department alleges that the medical providers engaged in systematic overbilling of Medicare and TRICARE, the healthcare program for U.S…. Read More »
Two Testing Labs Agree to Settle False Claims Act Suits
The Justice Department announced that two cardiovascular testing laboratories, Health Diagnostics Laboratory, Inc. (“HDL”) and Singulex, Inc. have agreed to settle allegations that they violated the Anti-Kickback Stature and the False Claims Act. HDL and Singulex will pay $47 million and $1.5 million, respectively. According to its website, HDL, based in Richmond, Virginia, offers… Read More »
Medtronic Settles False Claims Act Case for $4.41 Million
The Justice Department announced that Medtronic plc and its affiliates, Medtronic, Inc., Medtronic USA Inc., and Medtronic Sofamor Danek USA Inc. (collectively “Medtronic”) have agreed to settle three whistleblowers’ qui tam complaint alleging Medtronic violated the False Claims Act. Medtronic is a global healthcare company based in Minneapolis, Minnesota. According to its website, Medtronic’s… Read More »
Medical Device Company Agrees to Settle Lawsuit
According to the Department of Justice, ev3, Inc., formerly known as Fox Hollow Technologies, Inc., has agreed to settle a lawsuit alleging violations of the False Claims Act. The Justice Department announced that ev3 will pay $1.25 million to settle allegations that it caused hospitals to submit false claims to Medicare for inpatient admissions… Read More »
Drug Company Agrees to Settle Kickback Claims
According to the Justice Department, the drug company Daiichi Sankyo, Inc. (“Daiichi”) has agreed to settle allegations that it paid illegal kickbacks to physicians in violation of the False Claims Act and Anti-Kickback Statute. Daiichi is the U.S. subsidiary of global pharmaceutical company Daiichi Sankyo Co., Ltd. based in Tokyo, Japan. According to its… Read More »
AstraZeneca Settles Nexium Qui Tam Case
The Justice Department announced that AstraZeneca has agreed to settle a qui tam lawsuit brought by two whistleblowers concerning the gastrointestinal drug Nexium. The lawsuit alleged that AstraZeneca caused the submission of false claims to government health care programs Medicaid, Medicare, and TRICARE in violation of the federal and several states’ False Claims Acts… Read More »
Medical Company Agrees to Settle Whistleblower’s Case
According to the Justice Department, medical device manufacturer Medtronic, Inc. has agreed to settle a whistleblower’s qui tam case alleging it violated the False Claims Act by promoting a medical procedure that had not been approved by the Food and Drug Administration. The Justice Department said the allegations involved claims made to Medicare and… Read More »